Search

Jerry B. Dennison

Examiner (ID: 40, Phone: (571)272-3910 , Office: P/2443 )

Most Active Art Unit
2443
Art Unit(s)
2443, 2409, 2143, 2419
Total Applications
1015
Issued Applications
700
Pending Applications
74
Abandoned Applications
250

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18739581 [patent_doc_number] => 20230348537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => RATIONALLY-DESIGNED SYNTHETIC PEPTIDE SHUTTLE AGENTS FOR DELIVERING POLYPEPTIDE CARGOS FROM AN EXTRACELLULAR SPACE TO THE CYTOSOL AND/OR NUCLEUS OF A TARGET EUKARYOTIC CELL, USES THEREOF, METHODS AND KITS RELATING TO SAME [patent_app_type] => utility [patent_app_number] => 18/062234 [patent_app_country] => US [patent_app_date] => 2022-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66748 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 518 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062234 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/062234
Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same Dec 5, 2022 Issued
Array ( [id] => 19731272 [patent_doc_number] => 12209263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-28 [patent_title] => Optimized human clotting factor IX gene expression cassettes and their use [patent_app_type] => utility [patent_app_number] => 18/056424 [patent_app_country] => US [patent_app_date] => 2022-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 22767 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056424 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/056424
Optimized human clotting factor IX gene expression cassettes and their use Nov 16, 2022 Issued
Array ( [id] => 18649775 [patent_doc_number] => 20230295596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => SHORT-ACTING FACTOR VII POLYPEPTIDES [patent_app_type] => utility [patent_app_number] => 18/053577 [patent_app_country] => US [patent_app_date] => 2022-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18379 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053577 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/053577
SHORT-ACTING FACTOR VII POLYPEPTIDES Nov 7, 2022 Abandoned
Array ( [id] => 19106031 [patent_doc_number] => 11959116 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-16 [patent_title] => Method for producing nicotinamide mononucleotide [patent_app_type] => utility [patent_app_number] => 17/974381 [patent_app_country] => US [patent_app_date] => 2022-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10345 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17974381 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/974381
Method for producing nicotinamide mononucleotide Oct 25, 2022 Issued
Array ( [id] => 18628597 [patent_doc_number] => 20230287471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => METHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEINS BY RECOMBINANT METHODS [patent_app_type] => utility [patent_app_number] => 17/970051 [patent_app_country] => US [patent_app_date] => 2022-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10178 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970051 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/970051
METHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEINS BY RECOMBINANT METHODS Oct 19, 2022 Abandoned
Array ( [id] => 18391403 [patent_doc_number] => 20230159621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => METHOD FOR POLISHING ALBUMIN [patent_app_type] => utility [patent_app_number] => 18/046371 [patent_app_country] => US [patent_app_date] => 2022-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14101 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046371 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/046371
METHOD FOR POLISHING ALBUMIN Oct 12, 2022 Abandoned
Array ( [id] => 18310925 [patent_doc_number] => 20230114825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => De novo designed protein homodimers containing tunable symmetric pockets [patent_app_type] => utility [patent_app_number] => 17/938752 [patent_app_country] => US [patent_app_date] => 2022-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8559 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17938752 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/938752
De novo designed protein homodimers containing tunable symmetric pockets Oct 6, 2022 Pending
Array ( [id] => 18841668 [patent_doc_number] => 20230404071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => COMPOSITIONS, METHODS, AND APPLICATIONS OF A SYNTHETIC SURFACTANT [patent_app_type] => utility [patent_app_number] => 17/962153 [patent_app_country] => US [patent_app_date] => 2022-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14731 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17962153 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/962153
COMPOSITIONS, METHODS, AND APPLICATIONS OF A SYNTHETIC SURFACTANT Oct 6, 2022 Abandoned
Array ( [id] => 18077357 [patent_doc_number] => 20220402969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => Methods for Extracting Proteins from a Blood-Based Material [patent_app_type] => utility [patent_app_number] => 17/894593 [patent_app_country] => US [patent_app_date] => 2022-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9420 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17894593 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/894593
Methods for Extracting Proteins from a Blood-Based Material Aug 23, 2022 Abandoned
Array ( [id] => 18229755 [patent_doc_number] => 20230068749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS [patent_app_type] => utility [patent_app_number] => 17/890416 [patent_app_country] => US [patent_app_date] => 2022-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16587 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890416 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/890416
STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS Aug 17, 2022 Abandoned
Array ( [id] => 19011731 [patent_doc_number] => 11918632 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-05 [patent_title] => Pharmaceutical composition for diagnosing, preventing or treating liver cancer using SSU72 protein or a polynucleotide encoding the same [patent_app_type] => utility [patent_app_number] => 17/814579 [patent_app_country] => US [patent_app_date] => 2022-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 26 [patent_no_of_words] => 11852 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814579 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/814579
Pharmaceutical composition for diagnosing, preventing or treating liver cancer using SSU72 protein or a polynucleotide encoding the same Jul 24, 2022 Issued
Array ( [id] => 18389945 [patent_doc_number] => 20230158163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => TOXIN-DERIVED DELIVERY CONSTRUCTS [patent_app_type] => utility [patent_app_number] => 17/868077 [patent_app_country] => US [patent_app_date] => 2022-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17868077 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/868077
TOXIN-DERIVED DELIVERY CONSTRUCTS Jul 18, 2022 Abandoned
Array ( [id] => 18391684 [patent_doc_number] => 20230159902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => ALCOHOL DEHYDROGENASE VARIANTS [patent_app_type] => utility [patent_app_number] => 17/861036 [patent_app_country] => US [patent_app_date] => 2022-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39025 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861036 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/861036
ALCOHOL DEHYDROGENASE VARIANTS Jul 7, 2022 Abandoned
Array ( [id] => 18389911 [patent_doc_number] => 20230158129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => CLOSTRIDIAL TOXIN - HYALURONIC ACID COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/854334 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30000 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854334 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/854334
CLOSTRIDIAL TOXIN - HYALURONIC ACID COMPOSITIONS Jun 29, 2022 Abandoned
Array ( [id] => 18350067 [patent_doc_number] => 20230138178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => Methods and Compositions for Producing a Heterologous Antiviral Compound in a Host Cell [patent_app_type] => utility [patent_app_number] => 17/849327 [patent_app_country] => US [patent_app_date] => 2022-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8162 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17849327 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/849327
Methods and Compositions for Producing a Heterologous Antiviral Compound in a Host Cell Jun 23, 2022 Pending
Array ( [id] => 18568306 [patent_doc_number] => 20230258642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => COMPOSITIONS AND METHODS FOR IDENTIFICATION OF MODULATORS OF RAS PROTEIN COMPLEXES [patent_app_type] => utility [patent_app_number] => 17/808450 [patent_app_country] => US [patent_app_date] => 2022-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31183 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17808450 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/808450
COMPOSITIONS AND METHODS FOR IDENTIFICATION OF MODULATORS OF RAS PROTEIN COMPLEXES Jun 22, 2022 Abandoned
Array ( [id] => 17946022 [patent_doc_number] => 20220333039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => COMPOSITIONS COMPRISING ENZYMES [patent_app_type] => utility [patent_app_number] => 17/846696 [patent_app_country] => US [patent_app_date] => 2022-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28954 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17846696 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/846696
COMPOSITIONS COMPRISING ENZYMES Jun 21, 2022 Pending
Array ( [id] => 18210143 [patent_doc_number] => 20230056404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => SYSTEMS AND METHODS FOR PROTEIN EXPRESSION [patent_app_type] => utility [patent_app_number] => 17/839310 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839310 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/839310
SYSTEMS AND METHODS FOR PROTEIN EXPRESSION Jun 12, 2022 Pending
Array ( [id] => 17867465 [patent_doc_number] => 20220290201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => MEDIUM COMPOSITION FOR CULTURING ANIMAL CELLS FOR PRODUCING RECOMBINANT EXTRACELLULAR MATRIX PROTEIN AND METHOD OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/829032 [patent_app_country] => US [patent_app_date] => 2022-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10231 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829032 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/829032
MEDIUM COMPOSITION FOR CULTURING ANIMAL CELLS FOR PRODUCING RECOMBINANT EXTRACELLULAR MATRIX PROTEIN AND METHOD OF USING THE SAME May 30, 2022 Abandoned
Array ( [id] => 17960046 [patent_doc_number] => 20220340626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => PD-1 HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/738484 [patent_app_country] => US [patent_app_date] => 2022-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738484 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/738484
PD-1 homing endonuclease variants, compositions, and methods of use May 5, 2022 Issued
Menu